Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Dermatomycoses Global Market Report 2025
Download Free Sample Buy Now
Global Dermatomycoses Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Dermatomycoses Global Market Report 2025

By Drugs (Corticosteroids, Corticosteroid-Sparing Agents, Immunosuppressive, Immunomodulator, Antifungals, Other Drugs), By Route Of Administration ( Oral, Parenteral, Topical, Other Routes Of Administration), By End-User (Hospitals, Specialty Clinics, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Dermatomycoses Market Overview

• Dermatomycoses market size has reached to $14.12 billion in 2024

• Expected to grow to $18.17 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%

• Growth Driver: Increasing Prevalence Of Fungal Infections Fueling The Growth Of The Market Due To Rising Immunocompromised Population And Poor Hygiene

• Market Trend: Advancements In Onychomycosis Treatment With Investigational New Drug Developments In The Market

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Dermatomycoses Market?

Dermatomycoses are a group of fungal infections affecting the skin, hair, and nails, primarily caused by dermatophytes, yeasts, or molds. These infections often lead to itching, scaling, redness, and skin inflammation, impacting overall skin health. The main goal of treatment is to eliminate the fungal infection, alleviate symptoms, and prevent recurrence through the use of antifungal medications, maintaining proper hygiene, and following effective skin care practices.

The main drug types of dermatomycoses are corticosteroids, corticosteroid-sparing agents, immunosuppressive, immunomodulator, antifungals, others. Corticosteroids are anti-inflammatory drugs that help reduce swelling, redness, and itching in skin conditions. These are administered through various route of administration such as oral, parenteral, topical, others and are used by various end-users such as hospitals, specialty clinics, others.

Dermatomycoses Market Size and growth rate 2025 to 2029: Graph

What Is The Dermatomycoses Market Size 2025 And Growth Rate?

The dermatomycoses market size has grown strongly in recent years. It will grow from $14.12 billion in 2024 to $14.81 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to increasing advancements in antifungal therapies, increasing prevalence of fungal infections, rising awareness about skin health, increasing improved diagnostic techniques, and expansion of over-the-counter antifungal products.

What Is The Dermatomycoses Market Growth Forecast?

The dermatomycoses market size is expected to see strong growth in the next few years. It will grow to $18.17 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to the growing aging population, increasing incidence of drug-resistant fungal strains, rising demand for natural and organic antifungal products, increasing advancements in biotechnology and antifungal research, and expanding healthcare access in developing regions. Major trends in the forecast period include the development of novel antifungal drugs, advancement in rapid diagnostic techniques, integration of artificial intelligence in dermatology, advancement in nanotechnology-based antifungal treatments, and innovation in microbiome-based therapies.

The forecast of 5.3% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of systemic antifungals and diagnostic fungal culture media sourced from Spain and Canada, exacerbating treatment expenses for immunocompromised individuals. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Dermatomycoses Market Segmented?

1) By Drugs: Corticosteroids, Corticosteroid-Sparing Agents, Immunosuppressive, Immunomodulator, Antifungals, Other Drugs

2) By Route Of Administration: Oral, Parenteral, Topical, Other Routes Of Administration

3) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegmentss:

1) By Corticosteroids: Topical Corticosteroids, Oral Corticosteroids, Injectable Corticosteroids

2) By Corticosteroid-Sparing Agents: Tacrolimus, Pimecrolimus

3) By Immunosuppressive: Methotrexate, Azathioprine, Cyclophosphamide

4) By Immunomodulator: Interferon-Gamma, Thalidomide

5) By Antifungals: Topical Antifungals, Oral Antifungals, Systemic Antifungals

6) By Other Drugs: Antihistamines, Antibacterial Agents

What Is Driving The Dermatomycoses Market? Increasing Prevalence Of Fungal Infections Fueling The Growth Of The Market Due To Rising Immunocompromised Population And Poor Hygiene

The increasing prevalence of fungal infections is expected to propel the growth of the dermatomycoses market going forward. Fungal infections are conditions caused by fungi that infect the skin, nails, hair, or internal organs, resulting in different health issues. The excessive use of broad-spectrum antibiotics disrupts the natural microbiome, allowing fungi to thrive and cause infections. This imbalance weakens the body's natural defense mechanisms, making individuals more vulnerable to opportunistic fungal infections. Dermatomycoses, caused by dermatophytes, yeasts, and molds, are responsible for fungal diseases, affecting various tissues and causing common superficial and systemic infections. For instance, in November 2023, according to the UK Health Security Agency, a UK-based public health agency responsible for protecting public health from infectious diseases, global estimates indicate an annual incidence of 6.5 million invasive fungal infections, resulting in approximately 3.8 million deaths, with 2.5 directly attributed to these infections. Therefore, the increasing prevalence of fungal infections drives the dermatomycoses industry.

What Is Driving The Dermatomycoses Market? Rising Demand For Oral Drugs Fueling The Growth Of The Market Due To Their Convenience And Effectiveness

The rising demand for oral drugs is expected to propel the growth of the dermatomycoses market going forward. Oral drugs refer to medications that are taken by mouth in the form of tablets, capsules, or liquids and are absorbed through the digestive system. The demand for oral drugs is rising as they are a preferred choice over injections or other delivery methods due to their ease of convenience and effectiveness in treating a wide range of conditions. Dermatomycoses support the use of oral drugs by allowing systemic antifungal agents to penetrate infected skin, hair, or nails through blood circulation, ensuring deeper and prolonged treatment compared to topical applications. For instance, in October 2022, according to the Centers for Disease Control and Prevention, a US-based government administration, the dispensing of oral antivirals rose by 57%, increasing from 643 per 100,000 persons between April 24 and May 21, 2022, to 1,012 per 100,000 persons between July 31 and August 28, 2022. Therefore, the rising demand for oral drugs is driving the growth of the dermatomycoses industry.

Who Are The Major Players In The Global Dermatomycoses Market?

Major companies operating in the dermatomycoses market are Pfizer Inc., Bayer AG, Saphnix Life Sciences, MITS Healthcare Private Limited, Weefsel Pharma, AdvaCare Pharma, Associated Biotech, Healthy Life Pharma Private Limited, Blueberry Therapeutics Ltd., Livealth Biopharma Pvt. Ltd., LGM Pharma, SiNi Pharma Pvt. Ltd., Joshi Agrochem Pharma Private Limited, Wellona Pharma, Abiba Pharmacia Pvt. Ltd., Vee Excel Drugs & Pharmaceuticals Pvt. Ltd., Femcorp Pharma, Lexicare Pharma Pvt. Ltd., Glamris Dermacare, Henin Lukinz

What Are The Key Trends Of The Global Dermatomycoses Market? Advancements In Onychomycosis Treatment With Investigational New Drug Developments In The Market

Major companies operating in the dermatomycoses market are focusing on investigational new drugs candidate to advance onychomycosis treatment and improve efficacy. An investigational new drug (IND) candidate is a pharmaceutical compound undergoing preclinical or clinical trials to evaluate its safety, efficacy, and potential for regulatory approval before becoming an approved treatment. For instance, in January 2024, Vanda Pharmaceuticals Inc., a US-based biopharmaceutical company received Investigational New Drug VTR-297 candidate for the treatment of onychomycosis approved by the US Food and Drug Administration (FDA), a US-based government agency. VTR-297 stands out as a topical antifungal candidate due to its histone deacetylase (HDAC) inhibitor properties, distinguishing it from traditional antifungal treatments. This works by targeting the root cause of fungal growth, demonstrating potent antifungal activity against dermatophytes and other fungi. This innovative mechanism of action has the potential to deliver faster and more effective treatment results while also reducing the likelihood of infection recurrence, addressing a significant unmet need in onychomycosis treatment.

Need data on a specific region in this market?
Request Regional Data

What Is The Regional Outlook For The Global Dermatomycoses Market?

North America was the largest region in the dermatomycoses market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Dermatomycoses Market?

The dermatomycoses market consists of sales of barrier creams or protective skin creams, medicated soaps and body washes, and cryotherapy products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Dermatomycoses Industry?

The dermatomycoses market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the dermatomycoses industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Dermatomycoses Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $14.81 billion
Revenue Forecast In 2034 $18.17 billion
Growth Rate CAGR of 5.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The dermatomycoses market covered in this report is segmented –
1) By Drugs: Corticosteroids, Corticosteroid-Sparing Agents, Immunosuppressive, Immunomodulator, Antifungals, Other Drugs
2) By Route Of Administration: Oral, Parenteral, Topical, Other Routes Of Administration
3) By End-User: Hospitals, Specialty Clinics, Other End-Users Subsegmentss:
1) By Corticosteroids: Topical Corticosteroids, Oral Corticosteroids, Injectable Corticosteroids
2) By Corticosteroid-Sparing Agents: Tacrolimus, Pimecrolimus
3) By Immunosuppressive: Methotrexate, Azathioprine, Cyclophosphamide
4) By Immunomodulator: Interferon-Gamma, Thalidomide
5) By Antifungals: Topical Antifungals, Oral Antifungals, Systemic Antifungals
6) By Other Drugs: Antihistamines, Antibacterial Agents
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Bayer AG, Saphnix Life Sciences, MITS Healthcare Private Limited, Weefsel Pharma, AdvaCare Pharma, Associated Biotech, Healthy Life Pharma Private Limited, Blueberry Therapeutics Ltd., Livealth Biopharma Pvt. Ltd., LGM Pharma, SiNi Pharma Pvt. Ltd., Joshi Agrochem Pharma Private Limited, Wellona Pharma, Abiba Pharmacia Pvt. Ltd., Vee Excel Drugs & Pharmaceuticals Pvt. Ltd., Femcorp Pharma, Lexicare Pharma Pvt. Ltd., Glamris Dermacare, Henin Lukinz
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Dermatomycoses Market Characteristics

3. Dermatomycoses Market Trends And Strategies

4. Dermatomycoses Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Dermatomycoses Growth Analysis And Strategic Analysis Framework

5.1. Global Dermatomycoses PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Dermatomycoses Market Growth Rate Analysis

5.4. Global Dermatomycoses Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Dermatomycoses Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Dermatomycoses Total Addressable Market (TAM)

6. Dermatomycoses Market Segmentation

6.1. Global Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Corticosteroids

Corticosteroid-Sparing Agents

Immunosuppressive

Immunomodulator

Antifungals

Other Drugs

6.2. Global Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

Topical

Other Routes Of Administration

6.3. Global Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Other End-Users

6.4. Global Dermatomycoses Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Topical Corticosteroids

Oral Corticosteroids

Injectable Corticosteroids

6.5. Global Dermatomycoses Market, Sub-Segmentation Of Corticosteroid-Sparing Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tacrolimus

Pimecrolimus

6.6. Global Dermatomycoses Market, Sub-Segmentation Of Immunosuppressive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Methotrexate

Azathioprine

Cyclophosphamide

6.7. Global Dermatomycoses Market, Sub-Segmentation Of Immunomodulator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Interferon-Gamma

Thalidomide

6.8. Global Dermatomycoses Market, Sub-Segmentation Of Antifungals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Topical Antifungals

Oral Antifungals

Systemic Antifungals

6.9. Global Dermatomycoses Market, Sub-Segmentation Of Other Drugs, By Tyepe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antihistamines

Antibacterial Agents

7. Dermatomycoses Market Regional And Country Analysis

7.1. Global Dermatomycoses Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Dermatomycoses Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dermatomycoses Market

8.1. Asia-Pacific Dermatomycoses Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dermatomycoses Market

9.1. China Dermatomycoses Market Overview

9.2. China Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dermatomycoses Market

10.1. India Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dermatomycoses Market

11.1. Japan Dermatomycoses Market Overview

11.2. Japan Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dermatomycoses Market

12.1. Australia Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dermatomycoses Market

13.1. Indonesia Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dermatomycoses Market

14.1. South Korea Dermatomycoses Market Overview

14.2. South Korea Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dermatomycoses Market

15.1. Western Europe Dermatomycoses Market Overview

15.2. Western Europe Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dermatomycoses Market

16.1. UK Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dermatomycoses Market

17.1. Germany Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dermatomycoses Market

18.1. France Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dermatomycoses Market

19.1. Italy Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dermatomycoses Market

20.1. Spain Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dermatomycoses Market

21.1. Eastern Europe Dermatomycoses Market Overview

21.2. Eastern Europe Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dermatomycoses Market

22.1. Russia Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dermatomycoses Market

23.1. North America Dermatomycoses Market Overview

23.2. North America Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dermatomycoses Market

24.1. USA Dermatomycoses Market Overview

24.2. USA Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dermatomycoses Market

25.1. Canada Dermatomycoses Market Overview

25.2. Canada Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dermatomycoses Market

26.1. South America Dermatomycoses Market Overview

26.2. South America Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dermatomycoses Market

27.1. Brazil Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dermatomycoses Market

28.1. Middle East Dermatomycoses Market Overview

28.2. Middle East Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dermatomycoses Market

29.1. Africa Dermatomycoses Market Overview

29.2. Africa Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dermatomycoses Market Competitive Landscape And Company Profiles

30.1. Dermatomycoses Market Competitive Landscape

30.2. Dermatomycoses Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Saphnix Life Sciences Overview, Products and Services, Strategy and Financial Analysis

30.2.4. MITS Healthcare Private Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Weefsel Pharma Overview, Products and Services, Strategy and Financial Analysis

31. Dermatomycoses Market Other Major And Innovative Companies

31.1. AdvaCare Pharma

31.2. Associated Biotech

31.3. Healthy Life Pharma Private Limited

31.4. Blueberry Therapeutics Ltd.

31.5. Livealth Biopharma Pvt. Ltd.

31.6. LGM Pharma

31.7. SiNi Pharma Pvt. Ltd.

31.8. Joshi Agrochem Pharma Private Limited

31.9. Wellona Pharma

31.10. Abiba Pharmacia Pvt. Ltd.

31.11. Vee Excel Drugs & Pharmaceuticals Pvt. Ltd.

31.12. Femcorp Pharma

31.13. Lexicare Pharma Pvt. Ltd.

31.14. Glamris Dermacare

31.15. Henin Lukinz

32. Global Dermatomycoses Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dermatomycoses Market

34. Recent Developments In The Dermatomycoses Market

35. Dermatomycoses Market High Potential Countries, Segments and Strategies

35.1 Dermatomycoses Market In 2029 - Countries Offering Most New Opportunities

35.2 Dermatomycoses Market In 2029 - Segments Offering Most New Opportunities

35.3 Dermatomycoses Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Dermatomycoses Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Dermatomycoses Market, Sub-Segmentation Of Corticosteroid-Sparing Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Dermatomycoses Market, Sub-Segmentation Of Immunosuppressive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Dermatomycoses Market, Sub-Segmentation Of Immunomodulator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Dermatomycoses Market, Sub-Segmentation Of Antifungals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Dermatomycoses Market, Sub-Segmentation Of Other Drugs, By Tyepe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Dermatomycoses Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Dermatomycoses Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Pfizer Inc. Financial Performance
  • Table 81: Bayer AG Financial Performance
  • Table 82: Saphnix Life Sciences  Financial Performance
  • Table 83: MITS Healthcare Private Limited Financial Performance
  • Table 84: Weefsel Pharma Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Dermatomycoses Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Dermatomycoses Market, Sub-Segmentation Of Corticosteroid-Sparing Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Dermatomycoses Market, Sub-Segmentation Of Immunosuppressive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Dermatomycoses Market, Sub-Segmentation Of Immunomodulator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Dermatomycoses Market, Sub-Segmentation Of Antifungals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Dermatomycoses Market, Sub-Segmentation Of Other Drugs, By Tyepe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Dermatomycoses Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Dermatomycoses Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Dermatomycoses Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Dermatomycoses Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Dermatomycoses Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Pfizer Inc. Financial Performance
  • Figure 81: Bayer AG Financial Performance
  • Figure 82: Saphnix Life Sciences  Financial Performance
  • Figure 83: MITS Healthcare Private Limited Financial Performance
  • Figure 84: Weefsel Pharma Financial Performance

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Dermatology Drugs Global Market Report 2022 – By Type (Acne Drugs, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By R...

View Report

Dermatitis Global Market Report 2025 – By Drug Class (Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors ), By Distribution Channel (Ho...

View Report

Veterinary Dermatology Drugs Global Market Report 2025 – By Product Type( Antifungal Drugs, Antibacterial Drugs, Antiparasitic Drugs), By Animal Type( Companion Animal, Livestock Animal), By Drug Indication( Parasitic In...

View Report

Onychomycosis Global Market Report 2025 – By Type (Distal Subungual Onychomycosis (DSO), White Superficial Onychomycosis (WSO), Proximal Subungual Onychomycosis (PSO), Candida Onychomycosis, Other Types), By Treatment (D...

View Report

Dermatology Global Market Report 2025 – By Type (Medical Dermatology, Surgical Dermatology, Pediatric Dermatology, Cosmetic Dermatology, Cutaneous Lymphoma, Dermatoimmunology, Other Types ), By Application (Acne, Dermati...

View Report

Dermatophytosis Treatment Global Market Report 2025 – By Type (Prescribed, Over The Counter), By Product Type (Anti-infective, Antifungal, Steroids, Other Product Types), By Route Of Administration (Oral, Topical), By En...

View Report

Onychomycosis Treatment Global Market Report 2025 – By Type (Distal Sublingual Onychomycosis, White Superficial Onychomycosis, Proximal Sublingual Onychomycosis, Candida Onychomycosis, Other Types), By Treatment Type (Dr...

View Report

Dermatoscopes Global Market Report 2025 – By Product (Contact Dermatoscope, Hybrid Dermatoscope, Non-Contact Dermatoscope), By Technology (Light-Emitting Diode (LED), Xenon, Halogen, Ultraviolet), By Method (Handheld, Tr...

View Report

Frequently Asked Questions

Dermatomycoses are a group of fungal infections affecting the skin, hair, and nails, primarily caused by dermatophytes, yeasts, or molds. These infections often lead to itching, scaling, redness, and skin inflammation, impacting overall skin health. The main goal of treatment is to eliminate the fungal infection, alleviate symptoms, and prevent recurrence through the use of antifungal medications, maintaining proper hygiene, and following effective skin care practices. For further insights on this market, request a sample here

The market major growth driver - Increasing Prevalence Of Fungal Infections Fueling The Growth Of The Market Due To Rising Immunocompromised Population And Poor Hygiene. For further insights on this market, request a sample here

The dermatomycoses market size has grown steadily in recent years. It will grow from $14.12 billion in 2024 to $14.81 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to increasing advancements in antifungal therapies, increasing prevalence of fungal infections, rising awareness about skin health, increasing improved diagnostic techniques, and expansion of over-the-counter antifungal products. The dermatomycoses market size is expected to see strong growth in the next few years. It will grow to " $18.17 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to the growing aging population, increasing incidence of drug-resistant fungal strains, rising demand for natural and organic antifungal products, increasing advancements in biotechnology and antifungal research, and expanding healthcare access in developing regions. Major trends in the forecast period include the development of novel antifungal drugs, advancement in rapid diagnostic techniques, integration of artificial intelligence in dermatology, advancement in nanotechnology-based antifungal treatments, and innovation in microbiome-based therapies. For further insights on this market, request a sample here

The dermatomycosesmarket covered in this report is segmented –
1) By Drugs: Corticosteroids; Corticosteroid-Sparing Agents; Immunosuppressive; Immunomodulator; Antifungals; Other Drugs
2) By Route Of Administration: Oral; Parenteral; Topical; Other Routes Of Administration
3) By End-User: Hospitals; Specialty Clinics; Other End-Users Subsegments:
1) By Corticosteroids: Topical Corticosteroids; Oral Corticosteroids; Injectable Corticosteroids
2) By Corticosteroid-Sparing Agents: Tacrolimus; Pimecrolimus
3) By Immunosuppressive: Methotrexate; Azathioprine; Cyclophosphamide
4) By Immunomodulator: Interferon-Gamma; Thalidomide
5) By Antifungals: Topical Antifungals; Oral Antifungals; Systemic Antifungals
6) By Other Drugs: Antihistamines; Antibacterial Agents For further insights on this market, request a sample here

North America was the largest region in the dermatomycoses market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dermatomycoses market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the dermatomycoses market are Pfizer Inc., Bayer AG, Saphnix Life Sciences, MITS Healthcare Private Limited, Weefsel Pharma, AdvaCare Pharma, Associated Biotech, Healthy Life Pharma Private Limited, Blueberry Therapeutics Ltd., Livealth Biopharma Pvt. Ltd., LGM Pharma, SiNi Pharma Pvt. Ltd., Joshi Agrochem Pharma Private Limited, Wellona Pharma, Abiba Pharmacia Pvt. Ltd., Vee Excel Drugs & Pharmaceuticals Pvt. Ltd., Femcorp Pharma, Lexicare Pharma Pvt. Ltd., Glamris Dermacare, Henin Lukinz . For further insights on this market, request a sample here.

Major trends in this market include Advancements In Onychomycosis Treatment With Investigational New Drug Developments In The Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Dermatomycoses Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon